Grant Given from Prevent Blindness America to Help Treat Corneal Diseases

May 30, 2008

Contact: Public Affairs

Boston – (May 30, 2008) A grant from Prevent Blindness America has been awarded to corneal specialist Dr. Reza Dana, M.D. M.P.H., M.Sc, of the Massachusetts Eye and Ear Infirmary, to help fund his study “The Effectiveness and Safety of Topical Bevacizumab (Avastin) for Treatment of Corneal Growth of Blood Vessels that Obscure Vision.” The $35 thousand dollar grant will help Dr. Dana research and test the Avastin drug in order to help treat patients with this disease.

The objectives of Dr. Dana’s study are aimed to find a treatment for corneal diseases through testing patients on how often these diseases occur as well as how severe they are. He plans to accomplish this through eye exams and other physical examinations, reporting on subjects, and changes in blood pressure, as well as testing the effectiveness of the drug by documenting a series of follow-up photographs evaluating any progress.

Currently, there is no specific pharmaceutical treatment for the growth of blood vessels in the eye. Many take steroids, inject muscle relaxants, use laser surgery or membrane transplants, but all of these treatments have limitations. “We hope to use this grant to find a treatment for the growth of blood vessels in the eye so that many can have their vision back,” says Dana.